Table 2.
Clinical results before and after denosumab treatment
| Scoring system | Before treatment | After treatment | t or Z Value | p value |
|---|---|---|---|---|
| VAS* | 5.3 ± 2.7 | 2.0 ± 1.6 | 7.032 | < 0.001 |
| KPS† | 65 (40, 100) | 80 (60, 100) | − 3.652 | < 0.001 |
| ECOG | − 2.972 | 0.003 | ||
| 0 | 1 | 2 | ||
| 1 | 12 | 18 | ||
| 2 | 7 | 4 | ||
| 3 | 4 | 0 | ||
| Frankel grade | − 2.000 | 0.046 | ||
| D | 6 | 2 | ||
| E | 18 | 22 |
VAS, Visual Analog Scale; KPS, Karnofsky Performance Scale;ECOG, Eastern Cooperative Oncology Group
*The values are given as the mean and standard deviation
†The values are given as the median, with the range in parentheses